Publication:
Determination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors

Simple item page
dc.contributor.authorsDeniz, Semanur; Sancar, Mesut; Okuyan, Betul; Ata, Pinar; Bingol-Ozakpinar, Ozlem; Talas, Anil; Gunes, Tufan; Caliskan, Mecit; Izzettin, Fikret Vehbi
dc.date.accessioned2022-03-10T17:53:37Z
dc.date.accessioned2026-01-11T10:43:31Z
dc.date.available2022-03-10T17:53:37Z
dc.date.issued2015
dc.identifier.doidoiWOS:000349016600176
dc.identifier.eissn2210-7711
dc.identifier.issn2210-7703
dc.identifier.urihttps://hdl.handle.net/11424/221724
dc.identifier.wosWOS:000349016600176
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDetermination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage232
oaire.citation.issue1
oaire.citation.startPage231
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
oaire.citation.volume37

Files

Collections

Araştırma Çıktıları